Sectoral Asset Management Inc Global Blood Therapeutics, Inc. Transaction History

Sectoral Asset Management Inc

$120 Million
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$37.65 - $63.77 $9.61 Million - $16.3 Million	-255,271 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$52.76 - $74.49 $1.37 Million - $1.94 Million	26,000 Added 11.34%	255,271 $14.1 Million
Q2 2020 Aug 13, 2020	BUY	$48.73 - $81.82 $2.53 Million - $4.25 Million	51,977 Added 29.32%	229,271 $14.5 Million
Q1 2020 May 13, 2020	BUY	$41.72 - $87.2 $112,644 - $235,440	2,700 Added 1.55%	177,294 $9.06 Million
Q4 2019 Feb 12, 2020	SELL	$45.7 - $81.86 $3.04 Million - $5.44 Million	-66,446 Reduced 27.57%	174,594 $13.9 Million
Q3 2019 Nov 14, 2019	BUY	$45.35 - $57.91 $671,134 - $857,010	14,799 Added 6.54%	241,040 $11.7 Million
Q2 2019 Aug 14, 2019	SELL	$52.6 - $63.29 $2.48 Million - $2.98 Million	-47,100 Reduced 17.23%	226,241 $11.9 Million
Q1 2019 May 14, 2019	SELL	$39.99 - $53.48 $367,908 - $492,016	-9,200 Reduced 3.26%	273,341 $14.5 Million
Q4 2018 Feb 12, 2019	BUY	$31.54 - $46.67 $1.4 Million - $2.08 Million	44,500 Added 18.69%	282,541 $11.6 Million
Q3 2018 Nov 14, 2018	BUY	$38.0 - $51.1 $279,186 - $375,431	7,347 Added 3.18%	238,041 $9.05 Million
Q2 2018 Aug 13, 2018	BUY	$38.7 - $50.15 $1.69 Million - $2.19 Million	43,700 Added 23.37%	230,694 $10.4 Million
Q1 2018 May 15, 2018	SELL	$39.6 - $65.9 $10.1 Million - $16.8 Million	-254,774 Reduced 57.67%	186,994 $9.03 Million
Q4 2017 Feb 13, 2018	SELL	$29.7 - $45.7 $2.73 Million - $4.2 Million	-91,940 Reduced 17.23%	441,768 $17.4 Million
Q3 2017 Nov 14, 2017	BUY	$25.1 - $31.05 $13.4 Million - $16.6 Million	533,708	533,708 $16.6 Million

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.

Account